PEStore

Growth Equity

Lorient Capital

Lorient Capital takes minority stakes in growing companies, usually without full control, from United States. It states a focus on healthcare & life sciences.

Disclosed holdings23
Earliest stated investment2024
HeadquartersUnited States
Stated fund size$500M Fund III

Stated investment criteria

What Lorient Capital says it buys

Read from Lorient Capital’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

EBITDA it states$5m to $25m1
Transaction typesPlatform2
People listed on its team page293

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. Lorient Capital states that it takes majority or outright ownership. The team figure counts the people the firm shows on one team page, so it is a floor rather than a headcount: firms that split their team across tabs or load it in pages will read low. Nothing here is a commitment by Lorient Capital to consider any particular business, and nothing on this page is represented as being for sale.

Regulatory record

How Lorient Capital is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusSEC registered
Regulatory assets under management$1.9bn
Employees29
Private funds advised13 · $1.5bn gross
SEC adviser numberCRD 289572

Portfolio

Disclosed holdings

Companies Lorient Capital lists on its own website. 1 carry a stated investment year. 1 has a recorded transaction against it in the deal archive.

CompanyInvestedYears heldRecorded transaction
American Family Care20242
Altair Health
Behavior Frontiers
Centria Healthcare
ClearGage
Core Institute
Curana Health
Elite Patient Care
Healthy Living Network
Manor
MedCerts$70m 2020
Midwest Express Clinic
Pelvic Rehabilitation Medicine
PeterMD
Primor Health
PurposeCare
Reveal Dental
Reveal Dental Partners
ShiftKey
The CORE Institute
Transitions Care
Vet's Best Friend
Vitae Health Systems

Compiled from Lorient Capital’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Lorient Capital?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other growth equity investors active in healthcare & life sciences.